For example, in hepatocellular carcinoma (HCC), p62 supports carcinogenesis through activation of Nrf2 [23], in papillary thyroid cancer through mTOR activation [24] or in lung adenocarcinomas through NF-κB activation [25]. This evidence concerns the gene MTOR and hepatocellular carcinoma.